​

Inventiva (IVA) Stock Forecast, Price Target & Predictions

OverviewOwnershipChartTranscripts

IVA Stock Forecast

Inventiva (IVA) stock forecast, based on 9 Wall Street analysts, predicts a 12-month average price target of $14.00, with a high of $14.00 and a low of $14.00. This represents a 279.40% increase from the last price of $3.69.

- $3 $6 $9 $12 $15 High: $14 Avg: $14 Low: $14 Last Closed Price: $3.69

IVA Stock Rating

Inventiva stock's rating consensus is Buy, based on 9 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (88.89%), 0 Hold (0.00%), 1 Sell (11.11%), and 0 Strong Sell (0.00%).

Buy
Total 9 0 1 0 8 Strong Sell Sell Hold Buy Strong Buy

IVA Price Target Upside V Benchmarks

TypeNameUpside
StockInventiva279.40%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts-16
Avg Price Target-$14.00$15.50
Last Closing Price$3.69$3.69$3.69
Upside/Downside-279.40%320.05%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 26112---13
Sep, 26211---13
Aug, 26211---13
Jul, 26211---13
Jun, 26211---13
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 15, 2026Etzer DaroutGuggenheim$14.00$4.00250.00%279.40%
Jan 28, 2026Ananda GhoshH.C. Wainwright$24.00$6.97244.33%550.41%
Jan 27, 2026Barclays$18.00$6.87162.01%387.80%
Jan 12, 2026Leerink Partners$12.00$4.83148.45%225.20%
Jan 07, 2026Michael YeeUBS$12.00$4.54164.32%225.20%
Nov 05, 2025Wolfe Research$13.00$4.10217.07%252.30%
Sep 03, 2025Ananda GhoshH.C. Wainwright$20.00$5.74248.43%442.01%
Sep 02, 2025Guggenheim$13.00$5.26147.15%252.30%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 16, 2026Piper SandlerOverweightOverweighthold
Sep 15, 2026GuggenheimBuyBuyhold
Jul 17, 2026Cantor FitzgeraldOverweightinitialise
Jan 28, 2026H.C. WainwrightBuyBuyhold
Jan 27, 2026BarclaysOverweightinitialise
Nov 05, 2025Wolfe ResearchOutperforminitialise
Oct 09, 2025H.C. WainwrightBuyBuyhold
Sep 02, 2025GuggenheimBuyBuyhold
Aug 27, 2025Piper SandlerOverweightinitialise
Sep 26, 2024H.C. WainwrightBuyBuyhold

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.27$-1.31$-2.43-----
Avg Forecast$-1.68$-1.38$-1.93$-1.52$-0.91$-0.97$-0.93$-0.24
High Forecast$-1.09$-0.49$-1.60$-1.44$-0.66$-0.53$-0.73$-0.23
Low Forecast$-2.27$-2.73$-2.10$-1.59$-1.15$-1.23$-1.12$-0.25
Surprise %-24.40%-5.07%25.91%-----

Revenue Forecast

$0 $40M $80M $120M $160M $200M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$4.19M$12.18M$17.48M-----
Avg Forecast$5.45M$15.70M$13.37M$8.00M$16.74M$34.18M$92.28M$178.61M
High Forecast$6.92M$27.55M$21.77M$11.38M$19.51M$35.32M$95.37M$184.57M
Low Forecast$3.99M$7.92M$3.64M$4.62M$13.97M$33.03M$89.20M$172.64M
Surprise %-23.09%-22.44%30.74%-----

Net Income Forecast

$-150M $-120M $-90M $-60M $-30M $0 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-49.64M$-54.27M$-110.43M-----
Avg Forecast$-76.15M$-62.57M$-83.88M$-68.96M$-41.21M$-39.79M$-42.02M$-10.78M
High Forecast$-49.53M$-22.25M$-72.57M$-65.28M$-30.06M$-23.85M$-33.17M$-10.31M
Low Forecast$-102.77M$-123.91M$-95.20M$-72.33M$-52.36M$-55.73M$-50.87M$-11.25M
Surprise %-34.82%-13.26%31.64%-----

IVA Forecast FAQ

Is Inventiva stock a buy?

Inventiva stock has a consensus rating of Buy, based on 9 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 0 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Inventiva is a favorable investment for most analysts.

What is Inventiva's price target?

Inventiva's price target, set by 9 Wall Street analysts, averages $14 over the next 12 months. The price target range spans from $14 at the low end to $14 at the high end, suggesting a potential 279.40% change from the previous closing price of $3.69.

How does Inventiva stock forecast compare to its benchmarks?

Inventiva's stock forecast shows a 279.40% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Inventiva over the past three months?

  • October 2026: 7.69% Strong Buy, 92.31% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • September 2026: 15.38% Strong Buy, 84.62% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 15.38% Strong Buy, 84.62% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Inventiva’s EPS forecast?

Inventiva's average annual EPS forecast for its fiscal year ending in December 2024 is $-1.52, marking a -37.45% decrease from the reported $-2.43 in 2023. Estimates for the following years are $-0.91 in 2025, $-0.97 in 2026, $-0.93 in 2027, and $-0.24 in 2028.

What is Inventiva’s revenue forecast?

Inventiva's average annual revenue forecast for its fiscal year ending in December 2024 is $8M, reflecting a -54.24% decrease from the reported $17.48M in 2023. The forecast for 2025 is $16.74M, followed by $34.18M for 2026, $92.28M for 2027, and $178.61M for 2028.

What is Inventiva’s net income forecast?

Inventiva's net income forecast for the fiscal year ending in December 2024 stands at $-68.957M, representing a -37.55% decrease from the reported $-110M in 2023. Projections indicate $-41.21M in 2025, $-39.794M in 2026, $-42.02M in 2027, and $-10.78M in 2028.